Argos Therapeutics (ARGS) Tops Q3 EPS by 3c

November 14, 2016 6:58 AM EST
Get Alerts ARGS Hot Sheet
Trade ARGS Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with's Ratings Insider Elite. Get your Free Trial here.

Argos Therapeutics (NASDAQ: ARGS) reported Q3 EPS of ($0.32), $0.03 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $145.76 thousand versus the consensus estimate of $250 thousand.

For earnings history and earnings-related data on Argos Therapeutics (ARGS) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment